» Articles » PMID: 1590986

Molecular Approaches to Analysis of X-linked Immunodeficiencies

Overview
Date 1992 Jan 1
PMID 1590986
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Although the X-linked immunodeficiencies--X-linked agammaglobulinemia (XLA), X-linked severe combined immunodeficiency (XSCID), Wiskott-Aldrich syndrome (WAS), X-linked lymphoproliferative syndrome and X-linked hyper IgM syndrome--have been mapped to loci distributed throughout the X chromosome, they have several features in common that suggest that they might be members of a gene family: (i) all are maintained in the population at approximately the same gene frequency; (ii) expression of each defect is limited to the hematopoietic system; (iii) atypical forms of each disorder have been described; and (iv) obligate carriers of these disorders are normal by all immunologic criteria. The failure of carriers of XLA, XSCID, and WAS to show signs of their gene defects can be explained by the preferential use of the normal, nonmutant X as the active X in the cell lineages affected by the gene defects. These three disorders also share an additional feature; in boys with XLA, XSCID, or WAS there is asynchronous expression of cell surface markers of differentiation or activation. If some or all of the genes that are abnormal in the X-linked immunodeficiencies are members of a gene family, then isolation of one gene may lead to the others.

Citing Articles

Transplantation of human cells into Interleukin-2 receptor gamma gene knockout pigs under several conditions.

Hasegawa K, Nakano K, Nagaya M, Watanabe M, Uchikura A, Matsunari H Regen Ther. 2022; 21:62-72.

PMID: 35765545 PMC: 9198816. DOI: 10.1016/j.reth.2022.05.010.


Are patients with X-linked agammaglobulinemia at increased risk of developing acute lymphoblastic leukemia?.

Conley M J Clin Immunol. 2015; 35(2):98-9.

PMID: 25631529 DOI: 10.1007/s10875-015-0132-x.


Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer.

Drake J, Lee J, Witte O Mol Cell Biol. 2014; 34(10):1722-32.

PMID: 24567371 PMC: 4019040. DOI: 10.1128/MCB.01592-13.


A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Kuijpers T, van Leeuwen E, Barendregt B, Klarenbeek P, Aan de Kerk D, Baars P Haematologica. 2013; 98(7):1030-8.

PMID: 23403317 PMC: 3696605. DOI: 10.3324/haematol.2012.077511.


A case of Fabry's disease with congenital agammaglobulinemia.

Lee K, Jeon S, Hong J, Kim S, Song K, Kim Y J Korean Med Sci. 2011; 26(7):966-70.

PMID: 21738355 PMC: 3124732. DOI: 10.3346/jkms.2011.26.7.966.